10 completed, 5 unknown, 3 recruiting, 2 not yet recruiting. 10 Not applicable, 3 Phase 2, 3 Phase 3, 2 Phase 4, 1 Phase 1.
Follow Gout Flare: new trials by email Literature Review of Gout Flare trials Research Report on Gout Flare
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 24-Week Recurrence Rate of Gout Following Firsekibart Treatment Firsekibart - Gout Flare | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 264 | 2026-05-07 | 2026-06-04 |
| Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares Purified Cortophin Gel, 40 U, Purified Cortophin Gel 80 U - Gout Arthritis, Gout Flare | Phase 4 | Recruiting | Massachusetts General Hospital | 150 | 2025-12-20 | 2026-01-20 |
| Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare ABP-745 Dose A, ABP-745 Dose B, Colchicine - Acute Gouty Arthritis, Gout Flare | Phase 2 | Completed | Atom Therapeutics Co., Ltd | 479 | 2025-08-26 | 2026-10-28 |
| Developing A Gout Action Plan in Primary Care Setting in Singapore Gout action plan - Gout; Hyperuricemia, Gout Flare | Not applicable | Not yet recruiting | SingHealth Polyclinics | 72 | 2025-08-01 | 2025-07-11 |
| The Effects of Limb Elevation During Gout Flare Episodes limb elevation - Gout Flare | Not applicable | Unknown | Thammasat University | 30 | 2024-02-01 | 2024-01-16 |
| Treatment of Topical Ketorolac Gel in Acute Gouty Flare Ketorolac Tromethamine 15 MG/ML, Ketorolac Tromethamine - Acute Gouty Arthritis, Acute Pain | Phase 1 | Unknown | Novilla Pharmaceuticals | 30 | 2024-02-01 | 2024-02-23 |
| Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare Genakumab for injection, Colchicine - Acute Gout, Gout Flare | Phase 2 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 106 | 2023-07-21 | 2024-11-08 |
| Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Tigulixostat, Allopurinol, Placebo - Gout, Hyperuricemia | Phase 3 | Completed | LG Chem | 2202 | 2023-03-30 | 2025-07-22 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
| Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Tigulixostat, Placebo - Gout, Hyperuricemia | Phase 3 | Completed | LG Chem | 354 | 2022-10-25 | 2025-10-29 |
| Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout Gout Flare, Intercritical Gout | Unknown | Ai Peng | 600 | 2022-09-15 | 2024-05-08 | |
| Rural Hospital-Level Care at Home for Acutely Ill Adults Home Hospital care, Traditional Hospital care - Infections, Heart Failure | Not applicable | Completed | Brigham and Women's Hospital | 160 | 2022-02-16 | 2025-11-12 |
| Novel Biomarkers for Early Renal Injury in Children With Sepsis This study is an observational studie which have no intervention - Acute Kidney Injury, Sepsis | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 200 | 2021-05-01 | 2024-01-09 | |
| Prediction of Patient Deterioration Using Machine Learning Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2 - Infection, Heart Failure | Completed | Brigham and Women's Hospital | 526 | 2021-03-20 | 2026-03-17 | |
| Serum Potassium Prediction Using Machine Learning and Single-lead ECG Potassium estimation algorithm - Infection, Heart Failure | Withdrawn | Brigham and Women's Hospital | 2021-03-20 | 2026-03-25 | ||
| Prediction of Expected Length of Hospital Stay Using Machine Learning Infection, Heart Failure | Withdrawn | Brigham and Women's Hospital | 2021-03-20 | 2026-03-17 | ||
| Rural Home Hospital: Proof of Concept Home hospital care - Infection, Heart Failure | Not applicable | Completed | Brigham and Women's Hospital | 7 | 2021-02-18 | 2025-01-30 |
| Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare Colchicine,, midazolam,, fexofenadine - Gout Flare | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 26 | 2019-09-10 | 2024-06-03 |
| Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy simiaowan, placebo, febuxostat - Gout Flare | Not applicable | Unknown | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 72 | 2019-09-01 | 2019-08-30 |
| Remote Physician Care for Home Hospital Patients Remote Visit - Infection, Heart Failure | Not applicable | Completed | Brigham and Women's Hospital | 172 | 2019-08-03 | 2020-11-30 |
Showing 20 of 24. Sign in to see all of them.
Asthma (9) · Gout (9) · Heart Failure (9) · Hypertensive Crisis (9) · Infections (9) · Pulmonary Disease, Chronic Obstructive (9) · Renal Insufficiency, Chronic (9) · Hyperuricemia (4) · Arthritis (2) · Arthritis, Gouty (2) · Acute Kidney Injury (1) · Acute Pain (1) · Arthralgia (1) · Diabetes Mellitus (1) · Inflammation (1)
Pathological Conditions, Signs and Symptoms (15) · Pathologic Processes (14) · Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Kidney Diseases (10) · Male Urogenital Diseases (10) · Metabolic Diseases (10) · Nutritional and Metabolic Diseases (10) · Renal Insufficiency (10) · Urogenital Diseases (10) · Urologic Diseases (10) · Bronchial Diseases (9) · Cardiovascular Diseases (9) · Chronic Disease (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)
Colchicine (3) · Home Care Services, Hospital-Based (2) · Allopurinol (1) · Febuxostat (1) · Injections (1) · Ketorolac Tromethamine (1) · Midazolam (1) · dapansutrile (1) · fexofenadine (1) · simiaowan (1)
Brigham and Women's Hospital (9) · LG Chem (2) · Ai Peng (1) · Assistance Publique - Hôpitaux de Paris (1) · Atom Therapeutics Co., Ltd (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Guang'anmen Hospital of China Academy of Chinese Medical Sciences (1) · Massachusetts General Hospital (1) · Novilla Pharmaceuticals (1) · Olatec Therapeutics, Inc. (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sheffield Hallam University (1) · SingHealth Polyclinics (1) · Thammasat University (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (14) · China (6) · Australia (3) · France (3) · Thailand (3) · Georgia (2) · Philippines (2) · Spain (2) · Argentina (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Colombia (1) · Czechia (1)
David Levine, MD MPH MA (4) · Hyungjin Cho, MD (2) · Ai Peng, MD, PhD (1) · Hang-Korng EA, PhD, MD (1) · Hejian Zou (1) · Hyon K Choi, MD, DrPH (1) · Jeffrey Schnipper, MD, MPH (1) · Jiang Quan, Doctor (1) · Margo Barker (1) · Yaya Xu, M.S. (1)
PMID 39929260, PMID 12535399, PMID 12867348, PMID 22172492, PMID 22995041, PMID 24393558, PMID 26903390, PMID 27457514, PMID 27477556, PMID 27713240, PMID 29643150, PMID 30485934, PMID 30601717, PMID 31151457, PMID 31758246, PMID 31842232, PMID 32179562, PMID 32391934, PMID 32541923, PMID 32554059, PMID 32816816, PMID 33479931, PMID 33618661, PMID 33954888, PMID 34514294, PMID 34882311, PMID 36040741, PMID 36607199, PMID 37285198, PMID 37746085, PMID 38213387, PMID 38239283, PMID 40833487, PMID 41324962, PMID 42555132
2018 (1)